Phase I/IIa Study of SAR422459 in Patients With Stargardt's Macular Degeneration Primary Objective: To assess the safety and tolerability of ascending doses of SAR422459 in patients with Stargardt's Macular Degeneration. Secondary Objective: To evaluate ...

• Country France, United States
• organs None
• Specialty None

A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of UshStat® in Patients With Usher Syndrome Type 1B Primary Objective: To evaluate the long-term safety and tolerability of UshStat® in patients with Usher syndrome type 1B Secondary Objective: To assess long-term safety and ...

• Country None
• organs None
• Specialty None

Study of UshStat in Patients With Retinitis Pigmentosa Associated With Usher Syndrome Type 1B To evaluate the safety and tolerability of ascending doses of subretinal injections of UshStat in patients with Usher syndrome type 1B. To evaluate for possible biological activity of Ush...

• Country France, United States
• organs None
• Specialty None